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ABSTRACT Diagnosis of genital herpes requires a combination of 
clinical presentation and laboratory studies. Laboratory diagnostics 
allow us to clearly establish the etiology (HSV-1 or HSV-2) in order 
to determine the course of infection and prognosis. Decisive factors 
in the selection of the appropriate test are: diagnostic goals, patient 
population, specimen type, and implementation of conditions for 
the specific method. In total, 187 samples collected during a routine 
gynecological examination from 120 women were examined for 
the presence of HSV-1 and HSV-2 in the genital area. Two methods 
were used to test swabs: cell culture isolation and PCR. HSV-1 was the 
dominant type of virus in both study groups. The cytopathic effect 
was observed in 67 (35.8%) cultures with clinical material. HSV-1 and 
HSV-2 DNA were detected by PCR in 73 (39.0%) cell cultures infected 
with clinical samples. We did not observe typical, virus related cyto-
pathic changes in 13.7% DNA HSV positive cell cultures, but on the 
other hand we did not detect viral DNA in 6% of positive cell cultures. 
High values of the parameters, defining the usefulness of diagnostic 
tests (sensitivity, specificity, and predictive values) in both groups, 
are determined by previous viral replication in cell culture.
KEY WORDS: cell culture, cytopathic effect, diagnosis, genital her-
pes, HSV, PCR
INTRODUCTION
Genital herpes is one of the most common sexu-
ally transmitted diseases (STDs) worldwide. Herpes 
simplex viruses type 1 and 2 (HSV-1, HSV-2) respon-
sible for the disease belong to the genus Simplexvirus 
within the Alphaherpesvirinae subfamily of the Her-
pesviridae family. According to updated nomencla-
ture, there are two species of HSVs, human alphaher-
pesvirus 1 and human alphaherpesvirus 2. It is well-
established that while HSV-1 is the causative agent of 
cold sores, HSV-2 is the predominant cause of genital 
herpes. However, it has also been demonstrated that 
either type can be transmitted through oral, genital, 
or anal sexual contacts. According to current knowl-
edge, HSV-1 is responsible for about a half of the new 
cases of genital infections in some countries, and the 
frequency of isolation of HSV-1 from genital lesions 
has been increasing and requires constant monitor-
ing (1-7).
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Clinical presentation of genital herpes depends 
on both the host’s immune status and whether the in-
fection is primary or recurrent. In women, typical skin 
or mucosal manifestations include small (1-3 mm) 
vesicles on an erythematous base. After 24-48 hours, 
vesicles rupture and form painful ulcerations. The ap-
pearance of vesicles may be accompanied by dysuria, 
watery or mucous discharge from the urethra, and 
non-physiological secretions from the cervix. Inflam-
mation and lesions are located mainly on the cervix 
and/or the vulva and vagina but can be present in the 
urethra, on the inner surfaces of the thighs, buttocks, 
and anal area as well. Common signs include fever 
and enlargement of inguinal lymph nodes (3,4,6,8-
10). 
Typical clinical symptoms occur in only 20-40% 
of women with primary genital herpes infection, re-
gardless of the type of virus. As viral shedding can oc-
cur not only in the presence of lesions but also when 
symptoms are mild or do not occur at all, diagnosis 
based solely on clinical features is neither sensitive 
nor specific (2,5,8). The characteristic stage when the 
vesicles are present may be short-lasting, e.g. a few 
hours, especially if the changes are located on mu-
cosal membranes. Furthermore, lesions may appear 
in atypical or inaccessible locations. All these factors 
result in the fact that only approximately 20% of pa-
tients with genital herpes have been correctly diag-
nosed (4,8).  
Thus, diagnosis should rely on a combination of 
clinical presentation and laboratory examinations, 
which includes light microscopy cytology, virus cul-
tivation, detection of viral antigens, molecular meth-
ods, and serology. Diagnostic goals, patient popula-
tion, specimen type, and conditions for the imple-
mentation of the specific method are of decisive 
importance in the selection of the appropriate test. 
Only the selection of an appropriate method provides 
reliable interpretation and, as a consequence, imple-
mentation of algorithms for therapeutic and prophy-
lactic procedures (4,9,11,12). Laboratory diagnosis 
allows clear determination of the virus type (HSV-1 or 
HSV-2) in order to determine the course of infection 
and prognosis (10). Clinical signs of genital HSV-1 and 
HSV-2 outbreaks are similar, but the prognoses are 
quite different. Genital HSV-1 infection recurs less fre-
quently compared with HSV-2. It is well known that 
in HIV-infected persons, HSV-2 coinfection leads to 
increased quantities of HIV RNA in genital secretions 
and plasma, and shedding of HSV-2 is associated with 
higher frequency and amount of HIV-1 RNA in geni-
tal secretions (8). Studies report that HSV-2 accounts 
for nearly 70% of cases of neonatal herpes, a majority 
of which are due to intrapartum asymptomatic viral 
shedding in mothers without any sing and symptom 
of genital herpes (13). Unfortunately, according to 
our knowledge, it is not known what the contribution 
of HSV-1 in neonatal infections is, especially in popu-
lations where this type of virus is the one dominant in 
genital infection.
It is well known that screening in the general 
population is not indicated, but laboratory diagno-
sis is recommended for the confirmation of clinically 
suspected genital herpes, especially when symptoms 
or localization are atypical or for differential diagno-
sis with other ulcerative lesions: infectious (caused 
by inter alia Treponema pallidum and Haemophillus 
ducrei) or non-infectious (e.g. Crohn’s disease, Behcet 
syndrome, or fixed drug eruption) (1,4,11). Correct di-
agnosis is important for epidemiological reasons, as 
well (12). 
Virus isolation in cell culture is the gold standard 
for the diagnosis of HSV mucocutaneous infections; a 
high recovery rate is expected when lesions are fresh, 
which is why aspirated vesicle fluid samples or swabs, 
collected from the base of a lesion, should be tested. 
Proper handling and transport of the collected ma-
terials are critical for the upkeep of virus infectivity. 
Initial identification of the cytopathic effect requires 
confirmation with specific methods (4,11,13). Detec-
tion by the NAATs (nucleic acid amplification testing), 
such as polymerase chain reaction (PCR) or its modifi-
cations, is considered more rapid than virus isolation 
and more sensitive as well, even if sampling was per-
formed when the lesions have begun to crust over. 
The sensitivity of PCR highly depends on the amount 
of viral DNA collected from the site of infection. The 
main disadvantage is the risk of receiving false posi-
tive results due to contamination of the sample. The 
next restriction of PCR is small sample volume. Ad-
ditionally, procedures based on NAAT may present 
an increased number of positive results, with subse-
quent clinical dilemmas which can be related to the 
presence of viral DNA, but not the infectious virus 
(7,10,11,14).
Since the selection of a diagnostic method is high-
ly dependent on the stage of infection, we decided 
to analyze the usefulness of a combination of these 
Table 1. The results of identification of herpes vi-
ruses (HSV-1, HSV-2, or both) in clinical samples 
using PCR
HSV-1 HSV-2 HSV-1/HSV-2
Group of women suspected of having genital herpes
94% 3% 3%
Women without clinical signs of genital herpes
91% 6% 3%
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diagnostic methods in the study of clinical samples 
taken from women without the classical signs of in-
fection.
PATIENTS AND METHODS
Overall, 187 samples collected during a routine 
gynecological examination from 120 women were 
examined for the presence of HSV-1 and HSV-2 in the 
genital area. 
All patients signed informed consent forms. We 
analyzed 83 swabs taken from women with suspected 
genital herpes, but without typical lesions in the form 
of vesicles (history of recurrent nature of symptoms 
or discomfort, mild symptoms in the genital area) and 
104 swabs taken from asymptomatic women without 
prior clinical history of genital herpes. Swabs were 
taken from the vaginal vestibule, the cervix uteri, the 
vaginal part of cervix, vulva, the vaginal fornix, and 
the anorectal area. Depending on the patient’s status, 
the gynecologist made the decision about the place 
of sampling. When the time of sample storage was 
shorter than 24 h, samples were stored at 4 °C; in case 
of longer storage time, samples were kept frozen at 
-20 °C. Two methods were used to test swabs: virus 
isolation in cell culture and polymerase chain reac-
tion (PCR).
Specimens were obtained with soft-tipped da-
cron swabs and placed into 2 mL of viral transport 
medium; VTM (Copan, Italy). For virus isolation, con-
fluent 24h Vero cell culture (ATCC CCL-81) was used. 
Infected cells were monitored daily for morphologi-
cal changes under an inverted microscope (Olympus 
CK2, Germany). Detection of light refracting cells 
and ballooning degeneration with enlarged nuclei 
suggested infection caused by Alphaherpesvirinae. 
Infected cell culture supernatant was harvested at 
4-5 days post-infection or earlier if >50% cytopathic 
effect (CPE) was observed. If CPE was not observed, 
200 μl of supernatant was used for next passage. Up 
to five blind passages were performed for negative 
cultures. 
Total DNA was isolated from 200 µl of the culture 
supernatant using DNA Mini Kit (Qiagen, Germany) 
according to the manufacturer’s instructions (15). 
PCR was performed regardless of the result of the cell 
culture test. 
The statistical analyses were performed using chi-
square test with Yates correction for small groups at 
a confidence level of P<0.05. Sensitivity (SE), specific-
ity (SP), positive predictive value (PPV), and negative 
predictive value (NPV) were calculated. 
RESULTS
A cytopathic effect was observed in 67 (35.8%) cul-
tures infected with clinical material. In 60 cultures we 
observed characteristically enlarged, rounded cells. 
In the remaining 7 cultures we observed granulation, 
plaque formation, presence of filopodia-like cellular 
membrane protrusions, and small multinucleated 
syncytium formation. In 20 (out of 60; 33.3%) cultures, 
typical CPE appeared after 48 hours of cultivation and 
on the fifth day in 37 cultures (61.7%). The remaining 
samples (3; 5.0%) were found to be CPE positive after 
subsequent passages, so the analysis was extended 
to 14 days. In the 120 (64.2%) cell cultures infected 
with clinical material, there were no changes in the 
morphological structure of Vero cells during the 22 
days of observation.
Virus recovery rate in cell culture by mean of 
CPE production was similar in the group of women 
with non-characteristic mucosal or skin changes (30, 
44.8%) when compared with the group of asymptom-
atic patients (37, 55.2%), and this difference was not 
statistically significant (P>0.05) (Figure 1). Similarly, 
the frequency of viral DNA detection in cell cultures 
inoculated with the clinical material obtained from 
women with suspected infection (31, 42.5%) was not 
significantly higher when compared with the group 
of asymptomatic women (42, 57.5%, P>0.05). 
HSV-1 and HSV-2 DNA was detected with PCR in 
73 (39%) cell cultures infected with clinical material. 
Viral DNA was determined both in samples consid-
ered positive by the cell culture method (63; 33.7%) 
and in the samples prepared from the culture with-
out any morphological changes in the Vero cells 
(10; 5.3%), but the frequency of HSV DNA detec-
Table 2. Sensitivity, specificity, and predictive values of cell culture/PCR assay in the study of women sus-
pected of having genital herpes and without evidence of genital herpes
Tp Tn fp fn SE Sp ppV npV
Group of women suspected of having genital herpes
28 44 10 3 90.0% 81.0% 73.0% 86.0%
Women without clinical signs of genital herpes
35 64 0 7 83.3% 100.0% 100.0% 90.0%
SE: sensitivity; SP: specificity; TP: true positive results; TN: true negative results; FP: false positive results; FN: false negative 
results; PPV: positive predictive value; NPV: negative predictive value
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tion was significantly higher (37 vs. 26; P<0.01) in 
samples where CPE was observed (Figure 1). HSV-1 
was the dominant type of virus in both study groups 
(Table 1).
We decided to evaluate the diagnostic value of cell 
culture PCR assay in a study of two groups of women 
and compare it with the virus isolation method. Sen-
sitivity and specificity and predictive values (positive 
and negative) were calculated. The results are pre-
sented in Table 2. 
The sensitivity of integrated cell culture-based 
and PCR assay for diagnosis of genital herpes among 
women suspected of having infection and without 
clinical signs of infection was 90.0% and 83.3%, re-
spectively. The incidence of true negative results 
– reflected in the specificity of the test – was higher 
(100% vs. 81%) in asymptomatic women. In this group 
of patients, we were also observed a higher negative 
predictive value that expresses the probability that a 
negative result indicated no infection (90% vs. 86%). 
Among women suspected of having genital herpes 
and in the group of women without clinical signs of 
genital herpes, positive test results indicated that 
the probability of disease was estimated at 73% and 
100%, respectively. High values of the parameters in 
both groups were determined by previous viral repli-
cation in cell culture.
DISCUSSION 
The laboratory diagnosis of genital herpes is rec-
ommended for confirmation of clinically suspected 
infection, especially if symptoms are atypical. We 
have to remember that classical herpetic blisters are 
observed only in a minority of infected women. Re-
cent studies have shown that HSV reactivates much 
more frequently than previously thought and often 
sheds from skin or mucosal membranes in the ab-
sence of clinical signs. It is important to note that 
most genital herpes infections are transmitted in the 
absence of symptoms (8,12). As was shown by Wald 
and colleagues, the mean number of HSV DNA copies 
in samples taken from symptomatic and asymptom-
atic infected woman was 104.9 and 104.4, respectively 
(12). Tronstein and coworkers also found that the 
median log10 HSV-2 DNA copy number among the 
participants who reported lesions and among per-
sons who remained asymptomatic was similar (4.8 
vs. 4.1) (16). Likewise, many neonatal infections result 
from asymptomatic cervical shedding of HSV after an 
episode of genital herpes at the time of delivery (8). 
Therefore, there is a tremendous need to monitor cer-
tain groups of people for the presence of the virus in 
the the anogenital area and selection of the  appro-
priate diagnostic method is critical (3,16). 
No patients had typical symptoms in our study. 
We therefore decided to propagate viruses from clini-
cal samples in culture and subsequently detect the vi-
ral genetic material. Regarded in that light, our results 
indicate that this integrated cell culture PCR assay is 
highly sensitive for diagnosis of genital herpes and 
can be applied even to the detection of asymptom-
atic infection in order to detect asymptomatic genital 
viral shedding (e.g. for epidemiological purposes, to 
detect the virus on the surface of the mucous mem-
branes of the pregnant woman’s birth canal, in HIV-
infected individuals, or sexual partners of herpes in-
fected men).
Virus isolation in cell culture is considered the gold 
standard for genital herpes diagnosis. The success 
of this method depends on the choice, collection, 
and transport of clinical specimens and type of cell 
culture used (1,4,12,13,17). Fluid aspirated from the 
vesicles or smear from the base of an intact vesicle is 
the best clinical sample (18). The sensitivity depends 
on the viral titer and varies from 90-95% for vesicles 
to 17-35% for crusted lesions (1,4,11). Standard viral 
isolation takes 1-7 days to the appearance of degen-
erative changes in cells inoculated with the virus. 
CPE in cells infected with HSV-1 and HSV-2 are quite 
distinct but not unique. Additionally, morphologic 
changes of the cell line induced by other viruses, tox-
ins, or even Trichomonas vaginalis can be confused 
with HSV (19). This method classifies the virus as a 
part of the Alphaherpesvirinae subfamily. Both HSV 
and Varicella zoster virus (VZV) are members of the vi-
ral Alphaherpesvirinae, so confirmation with another 
method, e.g. PCR, should be subsequently conducted 
(3). It should be noted that the absence of visible cy-
topathic changes does not exclude presence of the 
pathogen (1,4,5,13). We would like to emphasize that 
Figure 1. The detection of HSV DNA in CPE+ and CPE- sam-
ples taken from women suspected of having genital herpes 
and from women without local signs of infection.
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the interpretation of CPE requires substantial experi-
ence. Observed cytopathic changes may differ from 
those commonly described. This can be caused by 
mutations that affect the HSV membrane proteins, 
which play an important role in viral entry and fusion 
of infected cells with neighboring cells. The conse-
quences of those processes are cytopathic changes 
in HSV infected cells, such as polykaryocytes, plaques, 
and syncytia (syn phenotype). It is worth noting that 
the virulence of the syncytium-forming strain has not 
been clarified, but researchers have suggested that 
these strains may present some characteristics of the 
attenuated virus. This hypothesis is supported by the 
finding that most of tested syncytial mutants were 
less virulent than nonsyncytial strains after corneal 
infection of rabbits or footpad and vaginal infection 
of mice (20-22).  
CONSLUSIONS
In our study, we did not detect viral DNA in 6.0% 
of positive cell cultures, but on the other hand we 
detected DNA HSV in 13.7% negative cell cultures 
(with no CPE indicative of herpes infection). The false 
negatives in cell culture assay can be due to the slow 
growth of wild strains in vitro or low titer of the vi-
rus in the specimens. It is worth noting that negative 
results never mean the absence of herpes disease 
(14). Laboratory diagnosis combining two methods 
allowed us to achieve high test sensitivity, especially 
among women suspected of having infection (90%). 
We evaluated the feasibility of such a procedure ana-
lyzing the positive and negative predictive values. 
Obtained rates were high enough to recommend an 
integrated cell culture-based and PCR assay for the 
detection of asymptomatic genital viral shedding and 
diagnosis of genital herpes in asymptomatic infected 
woman or those with no characteristic sign of infec-
tion. According to the literature, laboratory diagnosis 
of genital herpes in men is less complicated (e.g. due 
to the anatomical structure of the genital organs) so 
we cannot confirm whether this integrated cell cul-
ture/ PCR assay is more useful than single-step diag-
nostics i.e. detection of viral DNA in signs located on 
the genital area.
We also found that analysis the material taken 
from different anatomic locations in the genital tract 
can be the good practice in women. Such an ap-
proach can increase the probability of recognition of 
infection and thus reduce the risk of false negative 
results (5). 
Furthermore, virus culture allows us to perform a 
phenotypic drug susceptibility assay if necessary. And 
lastly, it is also important to provide access to labora-
tory diagnosis of genital herpes, especially in devel-
oping countries or selected, clearly defined popula-
tions, and then choose the most optimal method 
enabling the diagnosis of genital infection in specific 
patients. The use of improper methods or failure to 
comply with the procedures not only leads to false 
results, but also falsifies epidemiological data (12).
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